<!DOCTYPE html>
<html>
<head>
<style>
table {
    font-family: arial, sans-serif;
    border-collapse: collapse;
    width: 100%;
}
td, th {
    border: 1px solid #dddddd;
    text-align: left;
    padding: 8px;
}
tr:nth-child(even) {
    background-color: #dddddd;
}
</style>
</head>
<body>

<table>
<tr>
<th>No.</th>
<th>Pathway</th>
<th>positive..r.</th>
<th>measured..n.</th>
<th>total</th>
<th>X.</th>
<th>Z.Score</th>
<th>p.value..permuted.</th>
<tr>



<tr>
<td>1</td>
<td> <a href="Pathways/Gastric Cancer Network 1/Gastric Cancer Network 1.html">Gastric Cancer Network 1</td>
<td>3</td>
<td>28</td>
<td>32</td>
<td>10.71%</td>
<td>3.66</td>
<td>0.004</td>
</tr>
<tr>
<td>2</td>
<td> <a href="Pathways/Osteoblast Signaling/Osteoblast Signaling.html">Osteoblast Signaling</td>
<td>2</td>
<td>14</td>
<td>18</td>
<td>14.29%</td>
<td>3.62</td>
<td>0.012</td>
</tr>
<tr>
<td>4</td>
<td> <a href="Pathways/Fluoropyrimidine Activity/Fluoropyrimidine Activity.html">Fluoropyrimidine Activity</td>
<td>3</td>
<td>33</td>
<td>57</td>
<td>9.09%</td>
<td>3.26</td>
<td>0.006</td>
</tr>
<tr>
<td>5</td>
<td> <a href="Pathways/Cell Cycle/Cell Cycle.html">Cell Cycle</td>
<td>6</td>
<td>102</td>
<td>108</td>
<td>5.88%</td>
<td>3.25</td>
<td>0.005</td>
</tr>
<tr>
<td>6</td>
<td> <a href="Pathways/DNA IR-damage and cellular response via ATR/DNA IR-damage and cellular response via ATR.html">DNA IR-damage and cellular response via ATR</td>
<td>5</td>
<td>79</td>
<td>91</td>
<td>6.33%</td>
<td>3.16</td>
<td>0.01</td>
</tr>
<tr>
<td>7</td>
<td> <a href="Pathways/miR-517 relationship with ARCN1 and USP1/miR-517 relationship with ARCN1 and USP1.html">miR-517 relationship with ARCN1 and USP1</td>
<td>1</td>
<td>5</td>
<td>7</td>
<td>20.00%</td>
<td>3.14</td>
<td>0.025</td>
</tr>
<tr>
<td>8</td>
<td> <a href="Pathways/Secretion of Hydrochloric Acid in Parietal Cells/Secretion of Hydrochloric Acid in Parietal Cells.html">Secretion of Hydrochloric Acid in Parietal Cells</td>
<td>1</td>
<td>5</td>
<td>15</td>
<td>20.00%</td>
<td>3.14</td>
<td>0.014</td>
</tr>
<tr>
<td>9</td>
<td> <a href="Pathways/Sulindac Metabolic Pathway/Sulindac Metabolic Pathway.html">Sulindac Metabolic Pathway</td>
<td>1</td>
<td>5</td>
<td>11</td>
<td>20.00%</td>
<td>3.14</td>
<td>0.009</td>
</tr>
<tr>
<td>10</td>
<td> <a href="Pathways/Type II interferon signaling (IFNG)/Type II interferon signaling (IFNG).html">Type II interferon signaling (IFNG)</td>
<td>3</td>
<td>37</td>
<td>38</td>
<td>8.11%</td>
<td>2.99</td>
<td>0.01</td>
</tr>
<tr>
<td>11</td>
<td> <a href="Pathways/Retinoblastoma (RB) in Cancer/Retinoblastoma (RB) in Cancer.html">Retinoblastoma (RB) in Cancer</td>
<td>5</td>
<td>87</td>
<td>98</td>
<td>5.75%</td>
<td>2.9</td>
<td>0.007</td>
</tr>
<tr>
<td>12</td>
<td> <a href="Pathways/Regulation of Apoptosis by Parathyroid Hormone-related Protein/Regulation of Apoptosis by Parathyroid Hormone-related Protein.html">Regulation of Apoptosis by Parathyroid Hormone-related Protein</td>
<td>2</td>
<td>22</td>
<td>24</td>
<td>9.09%</td>
<td>2.66</td>
<td>0.041</td>
</tr>
<tr>
<td>13</td>
<td> <a href="Pathways/Notch Signaling Pathway/Notch Signaling Pathway.html">Notch Signaling Pathway</td>
<td>3</td>
<td>45</td>
<td>48</td>
<td>6.67%</td>
<td>2.56</td>
<td>0.022</td>
</tr>
<tr>
<td>14</td>
<td> <a href="Pathways/Glial Cell Differentiation/Glial Cell Differentiation.html">Glial Cell Differentiation</td>
<td>1</td>
<td>7</td>
<td>9</td>
<td>14.29%</td>
<td>2.56</td>
<td>0.043</td>
</tr>
<tr>
<td>15</td>
<td> <a href="Pathways/miR-148a_miR-31_FIH1_HIF1Alpha-Notch signaling in glioblastoma/miR-148a_miR-31_FIH1_HIF1Alpha-Notch signaling in glioblastoma.html">miR-148a_miR-31_FIH1_HIF1Alpha-Notch signaling in glioblastoma</td>
<td>1</td>
<td>7</td>
<td>10</td>
<td>14.29%</td>
<td>2.56</td>
<td>0.027</td>
</tr>
<tr>
<td>16</td>
<td> <a href="Pathways/Pentose Phosphate Pathway/Pentose Phosphate Pathway.html">Pentose Phosphate Pathway</td>
<td>1</td>
<td>7</td>
<td>21</td>
<td>14.29%</td>
<td>2.56</td>
<td>0.028</td>
</tr>
<tr>
<td>17</td>
<td> <a href="Pathways/ATR Signaling/ATR Signaling.html">ATR Signaling</td>
<td>1</td>
<td>8</td>
<td>10</td>
<td>12.50%</td>
<td>2.34</td>
<td>0.058</td>
</tr>
<tr>
<td>18</td>
<td> <a href="Pathways/Glucocorticoid & Mineralcorticoid Metabolism/Glucocorticoid & Mineralcorticoid Metabolism.html">Glucocorticoid & Mineralcorticoid Metabolism</td>
<td>1</td>
<td>8</td>
<td>25</td>
<td>12.50%</td>
<td>2.34</td>
<td>0.039</td>
</tr>
<tr>
<td>19</td>
<td> <a href="Pathways/PPAR Alpha Pathway/PPAR Alpha Pathway.html">PPAR Alpha Pathway</td>
<td>2</td>
<td>26</td>
<td>28</td>
<td>7.69%</td>
<td>2.34</td>
<td>0.059</td>
</tr>
<tr>
<td>20</td>
<td> <a href="Pathways/Differentiation Pathway/Differentiation Pathway.html">Differentiation Pathway</td>
<td>3</td>
<td>50</td>
<td>64</td>
<td>6.00%</td>
<td>2.33</td>
<td>0.033</td>
</tr>
<tr>
<td>21</td>
<td> <a href="Pathways/Photodynamic therapy-induced unfolded protein response/Photodynamic therapy-induced unfolded protein response.html">Photodynamic therapy-induced unfolded protein response</td>
<td>2</td>
<td>27</td>
<td>28</td>
<td>7.41%</td>
<td>2.27</td>
<td>0.054</td>
</tr>
<tr>
<td>22</td>
<td> <a href="Pathways/T-Cell Receptor and Co-stimulatory Signaling/T-Cell Receptor and Co-stimulatory Signaling.html">T-Cell Receptor and Co-stimulatory Signaling</td>
<td>2</td>
<td>28</td>
<td>45</td>
<td>7.14%</td>
<td>2.21</td>
<td>0.014</td>
</tr>
<tr>
<td>23</td>
<td> <a href="Pathways/Liver X Receptor Pathway/Liver X Receptor Pathway.html">Liver X Receptor Pathway</td>
<td>1</td>
<td>10</td>
<td>12</td>
<td>10.00%</td>
<td>2.01</td>
<td>0.102</td>
</tr>
<tr>
<td>24</td>
<td> <a href="Pathways/Steroid Biosynthesis/Steroid Biosynthesis.html">Steroid Biosynthesis</td>
<td>1</td>
<td>10</td>
<td>25</td>
<td>10.00%</td>
<td>2.01</td>
<td>0.034</td>
</tr>
<tr>
<td>25</td>
<td> <a href="Pathways/Type III interferon signaling/Type III interferon signaling.html">Type III interferon signaling</td>
<td>1</td>
<td>10</td>
<td>11</td>
<td>10.00%</td>
<td>2.01</td>
<td>0.104</td>
</tr>
<tr>
<td>26</td>
<td> <a href="Pathways/PTF1A related regulatory pathway/PTF1A related regulatory pathway.html">PTF1A related regulatory pathway</td>
<td>1</td>
<td>11</td>
<td>12</td>
<td>9.09%</td>
<td>1.88</td>
<td>0.131</td>
</tr>
<tr>
<td>27</td>
<td> <a href="Pathways/Vitamin D Metabolism/Vitamin D Metabolism.html">Vitamin D Metabolism</td>
<td>1</td>
<td>11</td>
<td>21</td>
<td>9.09%</td>
<td>1.88</td>
<td>0.037</td>
</tr>
<tr>
<td>28</td>
<td> <a href="Pathways/MAPK Signaling Pathway/MAPK Signaling Pathway.html">MAPK Signaling Pathway</td>
<td>8</td>
<td>248</td>
<td>259</td>
<td>3.23%</td>
<td>1.85</td>
<td>0.051</td>
</tr>
<tr>
<td>29</td>
<td> <a href="Pathways/Angiopoietin Like Protein 8 Regulatory Pathway/Angiopoietin Like Protein 8 Regulatory Pathway.html">Angiopoietin Like Protein 8 Regulatory Pathway</td>
<td>5</td>
<td>133</td>
<td>156</td>
<td>3.76%</td>
<td>1.82</td>
<td>0.048</td>
</tr>
<tr>
<td>30</td>
<td> <a href="Pathways/Integrin-mediated Cell Adhesion/Integrin-mediated Cell Adhesion.html">Integrin-mediated Cell Adhesion</td>
<td>4</td>
<td>100</td>
<td>102</td>
<td>4.00%</td>
<td>1.76</td>
<td>0.037</td>
</tr>
<tr>
<td>31</td>
<td> <a href="Pathways/Alanine and aspartate metabolism/Alanine and aspartate metabolism.html">Alanine and aspartate metabolism</td>
<td>1</td>
<td>12</td>
<td>66</td>
<td>8.33%</td>
<td>1.76</td>
<td>0.043</td>
</tr>
<tr>
<td>32</td>
<td> <a href="Pathways/Bone Morphogenic Protein (BMP) Signalling and Regulation/Bone Morphogenic Protein (BMP) Signalling and Regulation.html">Bone Morphogenic Protein (BMP) Signalling and Regulation</td>
<td>1</td>
<td>12</td>
<td>13</td>
<td>8.33%</td>
<td>1.76</td>
<td>0.129</td>
</tr>
<tr>
<td>33</td>
<td> <a href="Pathways/Gene regulatory network modelling somitogenesis/Gene regulatory network modelling somitogenesis.html">Gene regulatory network modelling somitogenesis</td>
<td>1</td>
<td>12</td>
<td>13</td>
<td>8.33%</td>
<td>1.76</td>
<td>0.127</td>
</tr>
<tr>
<td>34</td>
<td> <a href="Pathways/PDGF Pathway/PDGF Pathway.html">PDGF Pathway</td>
<td>2</td>
<td>38</td>
<td>52</td>
<td>5.26%</td>
<td>1.68</td>
<td>0.068</td>
</tr>
<tr>
<td>35</td>
<td> <a href="Pathways/BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation/BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation.html">BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation</td>
<td>1</td>
<td>13</td>
<td>16</td>
<td>7.69%</td>
<td>1.66</td>
<td>0.121</td>
</tr>
<tr>
<td>36</td>
<td> <a href="Pathways/Regulation of Actin Cytoskeleton/Regulation of Actin Cytoskeleton.html">Regulation of Actin Cytoskeleton</td>
<td>5</td>
<td>148</td>
<td>159</td>
<td>3.38%</td>
<td>1.56</td>
<td>0.067</td>
</tr>
<tr>
<td>38</td>
<td> <a href="Pathways/DNA Replication/DNA Replication.html">DNA Replication</td>
<td>2</td>
<td>42</td>
<td>50</td>
<td>4.76%</td>
<td>1.52</td>
<td>0.114</td>
</tr>
<tr>
<td>39</td>
<td> <a href="Pathways/Biogenic Amine Synthesis/Biogenic Amine Synthesis.html">Biogenic Amine Synthesis</td>
<td>1</td>
<td>15</td>
<td>33</td>
<td>6.67%</td>
<td>1.47</td>
<td>0.062</td>
</tr>
<tr>
<td>40</td>
<td> <a href="Pathways/Hedgehog Signaling Pathway/Hedgehog Signaling Pathway.html">Hedgehog Signaling Pathway</td>
<td>1</td>
<td>15</td>
<td>17</td>
<td>6.67%</td>
<td>1.47</td>
<td>0.164</td>
</tr>
<tr>
<td>41</td>
<td> <a href="Pathways/Integrated Cancer Pathway/Integrated Cancer Pathway.html">Integrated Cancer Pathway</td>
<td>2</td>
<td>44</td>
<td>50</td>
<td>4.55%</td>
<td>1.44</td>
<td>0.119</td>
</tr>
<tr>
<td>42</td>
<td> <a href="Pathways/NAD+ metabolism/NAD+ metabolism.html">NAD+ metabolism</td>
<td>1</td>
<td>16</td>
<td>34</td>
<td>6.25%</td>
<td>1.39</td>
<td>0.068</td>
</tr>
<tr>
<td>43</td>
<td> <a href="Pathways/Leptin Insulin Overlap/Leptin Insulin Overlap.html">Leptin Insulin Overlap</td>
<td>1</td>
<td>17</td>
<td>20</td>
<td>5.88%</td>
<td>1.32</td>
<td>0.199</td>
</tr>
<tr>
<td>44</td>
<td> <a href="Pathways/Exercise-induced Circadian Regulation/Exercise-induced Circadian Regulation.html">Exercise-induced Circadian Regulation</td>
<td>2</td>
<td>48</td>
<td>49</td>
<td>4.17%</td>
<td>1.31</td>
<td>0.121</td>
</tr>
<tr>
<td>45</td>
<td> <a href="Pathways/Circadian rythm related genes/Circadian rythm related genes.html">Circadian rythm related genes</td>
<td>6</td>
<td>209</td>
<td>210</td>
<td>2.87%</td>
<td>1.29</td>
<td>0.18</td>
</tr>
<tr>
<td>46</td>
<td> <a href="Pathways/Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway/Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway.html">Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway</td>
<td>1</td>
<td>18</td>
<td>19</td>
<td>5.56%</td>
<td>1.25</td>
<td>0.195</td>
</tr>
<tr>
<td>47</td>
<td> <a href="Pathways/Adipogenesis/Adipogenesis.html">Adipogenesis</td>
<td>4</td>
<td>129</td>
<td>132</td>
<td>3.10%</td>
<td>1.21</td>
<td>0.263</td>
</tr>
<tr>
<td>48</td>
<td> <a href="Pathways/Wnt Signaling Pathway Netpath/Wnt Signaling Pathway Netpath.html">Wnt Signaling Pathway Netpath</td>
<td>2</td>
<td>51</td>
<td>52</td>
<td>3.92%</td>
<td>1.21</td>
<td>0.146</td>
</tr>
<tr>
<td>49</td>
<td> <a href="Pathways/Apoptosis Modulation by HSP70/Apoptosis Modulation by HSP70.html">Apoptosis Modulation by HSP70</td>
<td>1</td>
<td>19</td>
<td>22</td>
<td>5.26%</td>
<td>1.19</td>
<td>0.228</td>
</tr>
<tr>
<td>50</td>
<td> <a href="Pathways/Farnesoid X Receptor  Pathway/Farnesoid X Receptor  Pathway.html">Farnesoid X Receptor  Pathway</td>
<td>1</td>
<td>19</td>
<td>21</td>
<td>5.26%</td>
<td>1.19</td>
<td>0.231</td>
</tr>
<tr>
<td>51</td>
<td> <a href="Pathways/Apoptosis-related network due to altered Notch3 in ovarian cancer/Apoptosis-related network due to altered Notch3 in ovarian cancer.html">Apoptosis-related network due to altered Notch3 in ovarian cancer</td>
<td>2</td>
<td>52</td>
<td>54</td>
<td>3.85%</td>
<td>1.18</td>
<td>0.148</td>
</tr>
<tr>
<td>52</td>
<td> <a href="Pathways/Hypertrophy Model/Hypertrophy Model.html">Hypertrophy Model</td>
<td>1</td>
<td>20</td>
<td>21</td>
<td>5.00%</td>
<td>1.13</td>
<td>0.227</td>
</tr>
<tr>
<td>53</td>
<td> <a href="Pathways/IL-4 Signaling Pathway/IL-4 Signaling Pathway.html">IL-4 Signaling Pathway</td>
<td>2</td>
<td>55</td>
<td>56</td>
<td>3.64%</td>
<td>1.09</td>
<td>0.147</td>
</tr>
<tr>
<td>54</td>
<td> <a href="Pathways/NRF2 pathway/NRF2 pathway.html">NRF2 pathway</td>
<td>4</td>
<td>141</td>
<td>145</td>
<td>2.84%</td>
<td>1.03</td>
<td>0.303</td>
</tr>
<tr>
<td>55</td>
<td> <a href="Pathways/Methionine De Novo and Salvage Pathway/Methionine De Novo and Salvage Pathway.html">Methionine De Novo and Salvage Pathway</td>
<td>1</td>
<td>22</td>
<td>74</td>
<td>4.55%</td>
<td>1.02</td>
<td>0.22</td>
</tr>
<tr>
<td>56</td>
<td> <a href="Pathways/Transcription factor regulation in adipogenesis/Transcription factor regulation in adipogenesis.html">Transcription factor regulation in adipogenesis</td>
<td>1</td>
<td>22</td>
<td>24</td>
<td>4.55%</td>
<td>1.02</td>
<td>0.278</td>
</tr>
<tr>
<td>57</td>
<td> <a href="Pathways/Regulation of toll-like receptor signaling pathway/Regulation of toll-like receptor signaling pathway.html">Regulation of toll-like receptor signaling pathway</td>
<td>4</td>
<td>142</td>
<td>153</td>
<td>2.82%</td>
<td>1.01</td>
<td>0.288</td>
</tr>
<tr>
<td>58</td>
<td> <a href="Pathways/Focal Adhesion/Focal Adhesion.html">Focal Adhesion</td>
<td>5</td>
<td>188</td>
<td>192</td>
<td>2.66%</td>
<td>1</td>
<td>0.274</td>
</tr>
<tr>
<td>59</td>
<td> <a href="Pathways/VEGFA-VEGFR2 Signaling Pathway/VEGFA-VEGFR2 Signaling Pathway.html">VEGFA-VEGFR2 Signaling Pathway</td>
<td>6</td>
<td>235</td>
<td>238</td>
<td>2.55%</td>
<td>0.99</td>
<td>0.373</td>
</tr>
<tr>
<td>60</td>
<td> <a href="Pathways/Nanoparticle triggered autophagic cell death/Nanoparticle triggered autophagic cell death.html">Nanoparticle triggered autophagic cell death</td>
<td>1</td>
<td>23</td>
<td>29</td>
<td>4.35%</td>
<td>0.97</td>
<td>0.233</td>
</tr>
<tr>
<td>136</td>
<td> <a href="Pathways/Notch Signaling Pathway/Notch Signaling Pathway.html">Notch Signaling Pathway</td>
<td>1</td>
<td>61</td>
<td>62</td>
<td>1.64%</td>
<td>-0.05</td>
<td>0.999</td>
</tr>






</table>

</body>
</html>